Correlation Engine 2.0
Clear Search sequence regions

  • adenoviruses (1)
  • angiogenesis (3)
  • Bach1 (13)
  • BACH1 protein (1)
  • blood flow (1)
  • btb poz (1)
  • drug target (1)
  • factor (3)
  • genes (1)
  • HDAC1 (4)
  • HDAC1 proteins (2)
  • hemoglobin (1)
  • HO- 1 (2)
  • human cells (1)
  • humans (1)
  • impairs (1)
  • ischemia (3)
  • matrigel (1)
  • mice (2)
  • patients (1)
  • protein human (2)
  • protein motifs (1)
  • protein- domain (2)
  • TCF4 (2)
  • VEGF (2)
  • Wnt (2)
  • β catenin (1)
  • Sizes of these terms reflect their relevance to your search.

    The transcription factor Bach1 impairs angiogenesis after ischemic injury by suppressing Wnt/β-catenin signaling; however, the specific domains responsible for the anti-angiogenic effects of Bach1 remain unclear. This study determined the role of the BTB domain of Bach1 in ischemic angiogenesis. Bach1 is highly expressed in circulating endothelial cells from acute myocardial infarction patients and is the early induction gene after ischemia. Mice were treated with adenoviruses coding for GFP (AdGFP), Bach1 (AdBach1), or a Bach1 mutant lacking the BTB domain (AdBach1-ΔBTB) after surgically induced hind-limb ischemia. Measures of blood-flow recovery, capillary density, and the expression of vascular endothelial growth factor (VEGF) and heme oxygenase-1 (HO-1) were significantly lower and ROS levels were higher in the AdBach1 group, but not in AdBach1-ΔBTB animals. Furthermore, transfection with AdBach1, but not AdBach1-ΔBTB, in human endothelial cells was associated with significant declines in 1) capillary density and hemoglobin content in the Matrigel-plug assay, 2) proliferation, migration, tube formation, and VEGF and HO-1 expression in endothelial cells. Bach1 binds directly with TCF4, and this interaction is mediated by residues 81-89 of the Bach1 BTB domain and the N-terminal domain of TCF4. Bach1, but not Bach1-ΔBTB, also co-precipitated with histone deacetylase 1 (HDAC1), while the full-length HDAC1 proteins, but not HDAC1 mutants lacking the protein-interaction domain, co-precipitated with Bach1. Collectively, these results demonstrate that the anti-angiogenic activity of Bach1 is crucially dependent on molecular interactions that are mediated by the protein's BTB domain, and this domain could be a drug target for angiogenic therapy. Copyright © 2019 The Author(s). Published by Elsevier B.V. All rights reserved.


    Li Jiang, Mengping Jia, Xiangxiang Wei, Jieyu Guo, Shengyu Hao, Aihong Mei, Xiuling Zhi, Xinhong Wang, Qinhan Li, Jiayu Jin, Jianyi Zhang, Shanqun Li, Dan Meng. Bach1-induced suppression of angiogenesis is dependent on the BTB domain. EBioMedicine. 2020 Jan;51:102617

    Expand section icon Mesh Tags

    Expand section icon Substances

    PMID: 31911270

    View Full Text